chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Hardness at arm of injection; Blood pressure went high again; Warm at arm of injection and feels the heat goes though her body; No appetite; Body burning, like heat inside body; Turned black my knuckles in my hand; Unpleasant feeling in chest area; Doctor says it is anxiety; Fatigue, couldn't get out of couch; Pain at injection site; Headache; This spontaneous case was reported by a health care professional and describes the occurrence of INDURATION (Hardness at arm of injection), BLOOD PRESSURE MEASUREMENT (Blood pressure went high again), VACCINATION SITE WARMTH (Warm at arm of injection and feels the heat goes though her body), DECREASED APPETITE (No appetite) and BURNING SENSATION (Body burning, like heat inside body) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension (Controlled).   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced INDURATION (Hardness at arm of injection), BLOOD PRESSURE MEASUREMENT (Blood pressure went high again), VACCINATION SITE WARMTH (Warm at arm of injection and feels the heat goes though her body), DECREASED APPETITE (No appetite), BURNING SENSATION (Body burning, like heat inside body), KNUCKLE PADS (Turned black my knuckles in my hand), CHEST DISCOMFORT (Unpleasant feeling in chest area), ANXIETY (Doctor says it is anxiety), FATIGUE (Fatigue, couldn't get out of couch), VACCINATION SITE PAIN (Pain at injection site) and HEADACHE (Headache). The patient was treated with LOSARTAN for Blood pressure high, at a dose of 25 mg, 2 pills at night; METOPROLOL SUCCINATE for Blood pressure high, at a dose of 25 mg once a day; ESCITALOPRAM OXALATE (LEXAPRO) at a dose of 10 UNK and SERTRALINE HYDROCHLORIDE (ZOLOFT) for Depression and Anxiety, at an unspecified dose and frequency. At the time of the report, INDURATION (Hardness at arm of injection), BLOOD PRESSURE MEASUREMENT (Blood pressure went high again), VACCINATION SITE WARMTH (Warm at arm of injection and feels the heat goes though her body), DECREASED APPETITE (No appetite), BURNING SENSATION (Body burning, like heat inside body), KNUCKLE PADS (Turned black my knuckles in my hand), CHEST DISCOMFORT (Unpleasant feeling in chest area), ANXIETY (Doctor says it is anxiety), FATIGUE (Fatigue, couldn't get out of couch), VACCINATION SITE PAIN (Pain at injection site) and HEADACHE (Headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm sore). On 15-Feb-2021, PAIN IN EXTREMITY (arm sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.     This case was linked to MOD-2021-051603 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Vaccination site pain
Clinical narrative: shoulder aches; severe headaches; pain in arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (shoulder aches), HEADACHE (severe headaches) and VACCINATION SITE PAIN (pain in arm of injection) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for Adverse event.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PAIN (pain in arm of injection). On 28-Jan-2021, the patient experienced ARTHRALGIA (shoulder aches) and HEADACHE (severe headaches). On 28-Jan-2021, ARTHRALGIA (shoulder aches), HEADACHE (severe headaches) and VACCINATION SITE PAIN (pain in arm of injection) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No Relevant concomitant medications was provided      This case was linked to MOD-2021-062310 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: TCR added, three NS events added from 2nd dose.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity, Palpitations, SARS-CoV-2 test
Clinical narrative: Rapid heartbeat; Palpitation; Arm sore/soreness on her arm; Headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Rapid heartbeat), PALPITATIONS (Palpitation), PAIN IN EXTREMITY (Arm sore/soreness on her arm), HEADACHE (Headache) and FATIGUE (fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Symptoms lasted until  first two weeks of January 2021) from 27-Dec-2020 to January 2021.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm sore/soreness on her arm), HEADACHE (Headache) and FATIGUE (fatigue). On 31-Mar-2021, the patient experienced TACHYCARDIA (Rapid heartbeat). 31-Mar-2021, the patient experienced PALPITATIONS (Palpitation). The patient was treated with ACETYLSALICYLIC ACID (BAYER ASPIRIN) at an unspecified dose and frequency. On 31-Mar-2021, TACHYCARDIA (Rapid heartbeat) and PALPITATIONS (Palpitation) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm sore/soreness on her arm), HEADACHE (Headache) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow-up received and added patient medical history, lab data, treatment drug and new event.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: Rapid heartbeat; Palpitation; Arm sore/soreness on her arm; Headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Rapid heartbeat), PALPITATIONS (Palpitation), PAIN IN EXTREMITY (Arm sore/soreness on her arm), HEADACHE (Headache) and FATIGUE (fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Symptoms lasted until  first two weeks of January 2021) from 27-Dec-2020 to January 2021.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm sore/soreness on her arm), HEADACHE (Headache) and FATIGUE (fatigue). On 31-Mar-2021, the patient experienced TACHYCARDIA (Rapid heartbeat). 31-Mar-2021, the patient experienced PALPITATIONS (Palpitation). The patient was treated with ACETYLSALICYLIC ACID (BAYER ASPIRIN) at an unspecified dose and frequency. On 31-Mar-2021, TACHYCARDIA (Rapid heartbeat) and PALPITATIONS (Palpitation) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm sore/soreness on her arm), HEADACHE (Headache) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow-up received and added patient medical history, lab data, treatment drug and new event.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal discomfort, Product dose omission issue
Clinical narrative: got the first dose of the Moderna vaccine on 08Feb2021 and has not gotten the second dose yet; their back went out on them and lasted for 4-5 days; This spontaneous case was reported by a physician and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (their back went out on them and lasted for 4-5 days) and PRODUCT DOSE OMISSION ISSUE (got the first dose of the Moderna vaccine on 08Feb2021 and has not gotten the second dose yet) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A or 001M20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  The patient's past medical history included Heart valve replacement (Aorta valve replacement). Concomitant products included TORSEMIDE, WARFARIN SODIUM (JANTOVEN), METOPROLOL, SPIRONOLACTONE, PANTOPRAZOLE, SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]) and PROBIOTICS NOS for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021 at 11:30 AM, the patient experienced MUSCULOSKELETAL DISCOMFORT (their back went out on them and lasted for 4-5 days). On 31-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (got the first dose of the Moderna vaccine on 08Feb2021 and has not gotten the second dose yet). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL DISCOMFORT (their back went out on them and lasted for 4-5 days) and PRODUCT DOSE OMISSION ISSUE (got the first dose of the Moderna vaccine on 08Feb2021 and has not gotten the second dose yet) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication also include stool softer and iron pill.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site induration, Vaccination site mass, Vaccination site pain, Vaccination site rash
Clinical narrative: very itchy; round circle and a hard bump; today where shot was given, arm is very hard; the rash is probably the size of a half dollar; at first only slightly sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (very itchy), VACCINATION SITE RASH (the rash is probably the size of a half dollar), VACCINATION SITE MASS (round circle and a hard bump), VACCINATION SITE INDURATION (today where shot was given, arm is very hard) and VACCINATION SITE PAIN (at first only slightly sore arm) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE PAIN (at first only slightly sore arm). On 31-Mar-2021, the patient experienced PRURITUS (very itchy), VACCINATION SITE RASH (the rash is probably the size of a half dollar), VACCINATION SITE MASS (round circle and a hard bump) and VACCINATION SITE INDURATION (today where shot was given, arm is very hard). At the time of the report, PRURITUS (very itchy), VACCINATION SITE RASH (the rash is probably the size of a half dollar), VACCINATION SITE MASS (round circle and a hard bump), VACCINATION SITE INDURATION (today where shot was given, arm is very hard) and VACCINATION SITE PAIN (at first only slightly sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medication and treatment information was provided.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site pain (arm is sore at the site of injection) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 007B2A) for COVID-19 immunization. No medical history reported. On Mar 31, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), unknown route; 1 dosage form. On Mar 31, 2021, patient experienced vaccination site pain (arm is sore at the site of injection). At the time of the report, vaccination site pain (arm is sore at the site of injection) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Concomitant medication provided: birth control pills. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). At the time of the report, OROPHARYNGEAL PAIN (sore throat) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant medication were reported. No treatment information was reported. Reporter did not allow further contact.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in arm; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Pain in arm) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     Concomitant products included MULTIVITAMINS [VITAMINS NOS] and CALCIUM, COLECALCIFEROL (CALCIUM VITAMIN D3 [CALCIUM;COLECALCIFEROL]) for Prevention.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). At the time of the report, PAIN IN EXTREMITY (Pain in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swelling of the lymph nodes under armpit; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swelling of the lymph nodes under armpit) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swelling of the lymph nodes under armpit). At the time of the report, LYMPHADENOPATHY (swelling of the lymph nodes under armpit) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dysstasia, Feeding disorder, Headache, Myalgia
Clinical narrative: Couldn't talk; Very nauseated; Could not stand; Not able to eat; Chills; Severe body ache; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSSTASIA (Could not stand), FEEDING DISORDER (Not able to eat), SPEECH DISORDER (Couldn't talk), CHILLS (Chills) and MYALGIA (Severe body ache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 15-Dec-2020 and Breast operation (breast cancer taken off last July). Concurrent medical conditions included Alcohol allergy.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced CHILLS (Chills), MYALGIA (Severe body ache) and HEADACHE (Headache). On 27-Mar-2021, the patient experienced DYSSTASIA (Could not stand) and FEEDING DISORDER (Not able to eat). On 29-Mar-2021, the patient experienced NAUSEA (Very nauseated). On an unknown date, the patient experienced SPEECH DISORDER (Couldn't talk). At the time of the report, DYSSTASIA (Could not stand), FEEDING DISORDER (Not able to eat), SPEECH DISORDER (Couldn't talk), CHILLS (Chills), MYALGIA (Severe body ache), HEADACHE (Headache) and NAUSEA (Very nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided. No Treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Speech disorder
Clinical narrative: Couldn't talk; Very nauseated; Could not stand; Not able to eat; Chills; Severe body ache; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSSTASIA (Could not stand), FEEDING DISORDER (Not able to eat), SPEECH DISORDER (Couldn't talk), CHILLS (Chills) and MYALGIA (Severe body ache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 15-Dec-2020 and Breast operation (breast cancer taken off last July). Concurrent medical conditions included Alcohol allergy.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced CHILLS (Chills), MYALGIA (Severe body ache) and HEADACHE (Headache). On 27-Mar-2021, the patient experienced DYSSTASIA (Could not stand) and FEEDING DISORDER (Not able to eat). On 29-Mar-2021, the patient experienced NAUSEA (Very nauseated). On an unknown date, the patient experienced SPEECH DISORDER (Couldn't talk). At the time of the report, DYSSTASIA (Could not stand), FEEDING DISORDER (Not able to eat), SPEECH DISORDER (Couldn't talk), CHILLS (Chills), MYALGIA (Severe body ache), HEADACHE (Headache) and NAUSEA (Very nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided. No Treatment information was provided.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Product administered to patient of inappropriate age, Vaccination site pain
Clinical narrative: pain all over the body quoted as " flu like symptoms"; soreness at injection site on the same day of vaccination; inappropriate age at vaccine administration; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (inappropriate age at vaccine administration), INFLUENZA LIKE ILLNESS (pain all over the body quoted as " flu like symptoms") and VACCINATION SITE PAIN (soreness at injection site on the same day of vaccination) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (unspecified). Concomitant products included FLUTICASONE for Allergy.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (inappropriate age at vaccine administration) and VACCINATION SITE PAIN (soreness at injection site on the same day of vaccination). On 26-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (pain all over the body quoted as " flu like symptoms"). On 25-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (inappropriate age at vaccine administration) outcome was unknown. At the time of the report, INFLUENZA LIKE ILLNESS (pain all over the body quoted as " flu like symptoms") and VACCINATION SITE PAIN (soreness at injection site on the same day of vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Additional info received
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Little bit of sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Little bit of sore arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included Chronic obstructive pulmonary disease.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Little bit of sore arm). At the time of the report, PAIN IN EXTREMITY (Little bit of sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchospasm, Disorientation, Dizziness, Peripheral swelling, Skin mass
Clinical narrative: arm being swollen and arm was about the size of a golf ball; arm was warm to the touch; lump in arm; lightheaded; disoriented; bronciospasms; wheezing and dyspnea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lightheaded), DISORIENTATION (disoriented), BRONCHOSPASM (bronciospasms; wheezing and dyspnea), PERIPHERAL SWELLING (arm being swollen and arm was about the size of a golf ball) and SKIN WARM (arm was warm to the touch) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced DIZZINESS (lightheaded), DISORIENTATION (disoriented) and BRONCHOSPASM (bronciospasms; wheezing and dyspnea). On 11-Apr-2021, the patient experienced PERIPHERAL SWELLING (arm being swollen and arm was about the size of a golf ball), SKIN WARM (arm was warm to the touch) and SKIN MASS (lump in arm). On 31-Mar-2021, BRONCHOSPASM (bronciospasms; wheezing and dyspnea) outcome was unknown. On 19-Apr-2021, PERIPHERAL SWELLING (arm being swollen and arm was about the size of a golf ball), SKIN WARM (arm was warm to the touch) and SKIN MASS (lump in arm) had resolved. At the time of the report, DIZZINESS (lightheaded) and DISORIENTATION (disoriented) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included Inhaler as needed. Treatment information included Nebulizer at home and  In hospital: Ativan through IV and inhaled Lidocaine.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Added new events peripheral swelling, skin warm and skin mass.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Skin warm
Clinical narrative: arm being swollen and arm was about the size of a golf ball; arm was warm to the touch; lump in arm; lightheaded; disoriented; bronciospasms; wheezing and dyspnea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lightheaded), DISORIENTATION (disoriented), BRONCHOSPASM (bronciospasms; wheezing and dyspnea), PERIPHERAL SWELLING (arm being swollen and arm was about the size of a golf ball) and SKIN WARM (arm was warm to the touch) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced DIZZINESS (lightheaded), DISORIENTATION (disoriented) and BRONCHOSPASM (bronciospasms; wheezing and dyspnea). On 11-Apr-2021, the patient experienced PERIPHERAL SWELLING (arm being swollen and arm was about the size of a golf ball), SKIN WARM (arm was warm to the touch) and SKIN MASS (lump in arm). On 31-Mar-2021, BRONCHOSPASM (bronciospasms; wheezing and dyspnea) outcome was unknown. On 19-Apr-2021, PERIPHERAL SWELLING (arm being swollen and arm was about the size of a golf ball), SKIN WARM (arm was warm to the touch) and SKIN MASS (lump in arm) had resolved. At the time of the report, DIZZINESS (lightheaded) and DISORIENTATION (disoriented) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included Inhaler as needed. Treatment information included Nebulizer at home and  In hospital: Ativan through IV and inhaled Lidocaine.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Added new events peripheral swelling, skin warm and skin mass.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Tenderness
Clinical narrative: Swollen and tender arm; tender arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (Swollen and tender arm) and TENDERNESS (tender arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 003B21A) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy (Allergic to Egg).   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swollen and tender arm) and TENDERNESS (tender arm). On 04-Mar-2021, PERIPHERAL SWELLING (Swollen and tender arm) and TENDERNESS (tender arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medication information was reported.   This case was linked to MOD-2021-064728 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: The patient received half of the dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (The patient received half of the dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (The patient received half of the dose). At the time of the report, ACCIDENTAL UNDERDOSE (The patient received half of the dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant Concomitant Medications were reported. No Treatment Information Provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pain in extremity
Clinical narrative: muscle pain back in both legs, muscle pain down to her knees and muscle pain in both upper arm from her shoulder to elbow; pain worsened; soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in the arm), MYALGIA (muscle pain back in both legs, muscle pain down to her knees and muscle pain in both upper arm from her shoulder to elbow) and PAIN (pain worsened) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     The patient's past medical history included Arthritis.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness in the arm). On an unknown date, the patient experienced MYALGIA (muscle pain back in both legs, muscle pain down to her knees and muscle pain in both upper arm from her shoulder to elbow) and PAIN (pain worsened). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (soreness in the arm), MYALGIA (muscle pain back in both legs, muscle pain down to her knees and muscle pain in both upper arm from her shoulder to elbow) and PAIN (pain worsened) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product was reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Feeling feverish; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Feeling feverish) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced PYREXIA (Feeling feverish). At the time of the report, PYREXIA (Feeling feverish) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications and treatment information were reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: Sore arm; Could hardly move it; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and MOBILITY DECREASED (Could hardly move it) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 015M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and MOBILITY DECREASED (Could hardly move it). At the time of the report, PAIN IN EXTREMITY (Sore arm) and MOBILITY DECREASED (Could hardly move it) outcome was unknown. Not Provided          The concomitant medications were not provided.  The treatment information was not provided.   The patient reported that her Chronic obstructive pulmonary disease got better after two shots of vaccine.She said she used nebulizer four times a day and that has went down to three times a day.  Oxygen level is up from 95 to 97. She said coughing got less, mucus not as bad, and has more energy.She said she had two COVID tests done on 6Feb, and 27Feb because she was getting cataract surgery on 10Feb and 3Mar. She said the benefits of the second shot have lessened a bit but not much. Breathing is easier and sleeping got better.   This case was linked to MOD21-066512 (E2B Linked Report).
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a 36-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 18-Nov-2020 and the estimated date of delivery was 03-Sep-2021. On 31-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  nineteenth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment information was not provided.  Patient wants to be a part of pregnancy registry.
Sex: U
Vaccine: COVID19
Symptoms: Nodule
Clinical narrative: nodule; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of NODULE (nodule) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included HYALURONIC ACID (RESTYLANE) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NODULE (nodule). At the time of the report, NODULE (nodule) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was reported.    Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2021: Follow up information was received and confirmed that the vaccine was Moderna.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Body temperature, Chills, Decreased appetite, Dizziness
Clinical narrative: didn't want to eat anything; very dizzy; falling asleep; stomach upset; very achy/Arm hurt more than after first dose; fever a little over 100; chills; tired; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (didn't want to eat anything), DIZZINESS (very dizzy), SOMNOLENCE (falling asleep), ABDOMINAL DISCOMFORT (stomach upset) and PAIN (very achy/Arm hurt more than after first dose) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 003B21A)) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Egg allergy.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced DECREASED APPETITE (didn't want to eat anything), DIZZINESS (very dizzy), SOMNOLENCE (falling asleep), ABDOMINAL DISCOMFORT (stomach upset), PAIN (very achy/Arm hurt more than after first dose), PYREXIA (fever a little over 100), CHILLS (chills) and FATIGUE (tired). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (didn't want to eat anything), DIZZINESS (very dizzy), SOMNOLENCE (falling asleep), ABDOMINAL DISCOMFORT (stomach upset), PAIN (very achy/Arm hurt more than after first dose), PYREXIA (fever a little over 100), CHILLS (chills) and FATIGUE (tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, Body temperature: 100 (High) fever a little over 100.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.    This case was linked to US-MODERNATX, INC.-MOD-2021-064687, US-MODERNATX, INC.-MOD-2021-058251 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-064687:dose 1 US-MODERNATX, INC.-MOD-2021-058251:Sister case
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia, Somnolence
Clinical narrative: didn't want to eat anything; very dizzy; falling asleep; stomach upset; very achy/Arm hurt more than after first dose; fever a little over 100; chills; tired; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (didn't want to eat anything), DIZZINESS (very dizzy), SOMNOLENCE (falling asleep), ABDOMINAL DISCOMFORT (stomach upset) and PAIN (very achy/Arm hurt more than after first dose) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 003B21A)) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Egg allergy.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced DECREASED APPETITE (didn't want to eat anything), DIZZINESS (very dizzy), SOMNOLENCE (falling asleep), ABDOMINAL DISCOMFORT (stomach upset), PAIN (very achy/Arm hurt more than after first dose), PYREXIA (fever a little over 100), CHILLS (chills) and FATIGUE (tired). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (didn't want to eat anything), DIZZINESS (very dizzy), SOMNOLENCE (falling asleep), ABDOMINAL DISCOMFORT (stomach upset), PAIN (very achy/Arm hurt more than after first dose), PYREXIA (fever a little over 100), CHILLS (chills) and FATIGUE (tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, Body temperature: 100 (High) fever a little over 100.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.    This case was linked to US-MODERNATX, INC.-MOD-2021-064687, US-MODERNATX, INC.-MOD-2021-058251 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-064687:dose 1 US-MODERNATX, INC.-MOD-2021-058251:Sister case
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Headache; cold chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (cold chills) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), CHILLS (cold chills) and PYREXIA (Fever). At the time of the report, HEADACHE (Headache), CHILLS (cold chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported. No treatment medications were taken.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Numbness in feet; Numbness; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in feet) and HYPOAESTHESIA (Numbness) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LOSARTAN, VENLAFAXINE and PHENTERMINE for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 30-Mar-2021, the patient experienced HYPOAESTHESIA (Numbness in feet) and HYPOAESTHESIA (Numbness). At the time of the report, HYPOAESTHESIA (Numbness in feet) and HYPOAESTHESIA (Numbness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment was not provided.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Oedema, Peripheral swelling
Clinical narrative: edema; some swelling in her feet that was very mild; This spontaneous case was reported by a health care professional and describes the occurrence of OEDEMA (edema) and PERIPHERAL SWELLING (some swelling in her feet that was very mild) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     The patient's past medical history included Chronic kidney disease stage 3, Autoimmune disorder NOS, Chronic interstitial cystitis NOS, Essential tremor, Pelvic floor dysfunction and Arthritis. Concomitant products included HYDROXYZINE, TOLTERODINE, URO MP, MELOXICAM and CYCLOBENZAPRINE for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OEDEMA (edema) and PERIPHERAL SWELLING (some swelling in her feet that was very mild). At the time of the report, OEDEMA (edema) and PERIPHERAL SWELLING (some swelling in her feet that was very mild) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   In addition to the above concomitant medications, the patient also uses a vaginal suppository which includes a combination of valium, ketamine, lidocaine and gabapentin per source document.   No treatment was specified after the first dose of the vaccine and the onset of the aforementioned adverse events. The patient was prescribed treatment after the second dose of the vaccine and onset of additional subsequent adverse events. Treatment included hydrochlorothiazide and propranolol.   This case was linked to MOD-2021-062259 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Rash, Rash pruritic
Clinical narrative: Itchy rash on upper arm; Blisters on upper arm; Red rash on upper arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchy rash on upper arm), BLISTER (Blisters on upper arm) and RASH (Red rash on upper arm) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced RASH PRURITIC (Itchy rash on upper arm), BLISTER (Blisters on upper arm) and RASH (Red rash on upper arm). At the time of the report, RASH PRURITIC (Itchy rash on upper arm), BLISTER (Blisters on upper arm) and RASH (Red rash on upper arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment medication included ice pack.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (she doesn't feel good.) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (she doesn't feel good.) and PYREXIA (fever). At the time of the report, FEELING ABNORMAL (she doesn't feel good.) and PYREXIA (fever) outcome was unknown. No treatment medication was provided. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Pain
Clinical narrative: Achy; stiff neck; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy) and MUSCULOSKELETAL STIFFNESS (stiff neck) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN (Achy) and MUSCULOSKELETAL STIFFNESS (stiff neck). The patient was treated with IBUPROFEN at a dose of 1 dosage form. On 31-Mar-2021, PAIN (Achy) and MUSCULOSKELETAL STIFFNESS (stiff neck) had resolved.            Concomitant product details was not provided by the reporter.   This case was linked to MOD21-066816 (Patient Link).